iANTHUS CAPITAL HOLDINGS (ITHUF) Current Assets (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Current Assets came in at $50.0 million in Q1 2026, down 20.66% year-on-year from $63.0 million in Q1 2025, and up 2.59% quarter-over-quarter from $48.7 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Current Assets (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Current Assets across 7 years of filings, most recently posting $50.0 million for Q1 2026.
- Current Assets for Q1 2026 came in at $50.0 million, down 20.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $50.0 million (down 20.66% YoY), and the FY2025 annual result was $48.7 million, down 34.71% from the prior year.
- Current Assets came in at $50.0 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from $48.7 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $74.6 million in Q4 2024 to a low of $45.5 million in Q4 2023.
- The 5-year median for Current Assets is $52.6 million (2023), against an average of $55.4 million.
- Across the five-year window, Current Assets surged 64.01% in 2024 and plunged 34.71% in 2025, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Current Assets stood at $50.6 million in 2022, then decreased by 10.1% to $45.5 million in 2023, then soared by 64.01% to $74.6 million in 2024, then slumped by 34.71% to $48.7 million in 2025, then advanced by 2.59% to $50.0 million in 2026.
- The last three Current Assets figures came in at $50.0 million (Q1 2026), $48.7 million (Q4 2025), and $52.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.71 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 6.47 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.87 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.44 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.58 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.36 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.05 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 942.29 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 50.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.00 Mn |
| Dec 31, 2025 | 48.73 Mn |
| Sep 30, 2025 | 52.79 Mn |
| Jun 30, 2025 | 58.04 Mn |
| Mar 31, 2025 | 63.02 Mn |
| Dec 31, 2024 | 74.64 Mn |
| Sep 30, 2024 | 54.64 Mn |
| Jun 30, 2024 | 52.43 Mn |
| Mar 31, 2024 | 49.16 Mn |
| Dec 31, 2023 | 45.51 Mn |
| Sep 30, 2023 | 50.65 Mn |
| Jun 30, 2023 | 52.05 Mn |
| Mar 31, 2023 | 52.62 Mn |
| Dec 31, 2022 | 50.62 Mn |
| Sep 30, 2022 | 59.34 Mn |
| Jun 30, 2022 | 68.56 Mn |
| Mar 31, 2022 | 58.88 Mn |
| Dec 31, 2021 | 53.65 Mn |
| Sep 30, 2021 | 62.83 Mn |
| Jun 30, 2021 | 62.17 Mn |